KD Logo

Atossa Therapeutics Inc (ATOS) rating initates by Maxim Group

In a filing, Atossa Therapeutics Inc revealed its Director Finn Jonathan acquired Company’s shares for reported $44250.0 on Apr 10 ’24. In the deal valued at $1.77 per share,25,000 shares were bought. As a result of this transaction, Finn Jonathan now holds 25,000 shares worth roughly $32500.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, WEAVER GREGORY L sold 50,000 shares, generating $32,500 in total proceeds. Upon selling the shares at $0.65, the Former EVP, CFO, & Director now owns 55 shares.

Maxim Group initiated its Atossa Therapeutics Inc [ATOS] rating to a Buy in a research note published on January 26, 2018; the price target was $2.

Price Performance Review of ATOS

On Tuesday, Atossa Therapeutics Inc [NASDAQ:ATOS] saw its stock jump 4.84% to $1.30. Over the last five days, the stock has gained 7.44%. Atossa Therapeutics Inc shares have risen nearly 47.73% since the year began. Nevertheless, the stocks have risen 23.81% over the past one year. While a 52-week high of $2.31 was reached on 04/05/24, a 52-week low of $0.62 was recorded on 01/25/24. SMA at 50 days reached $1.2504, while 200 days put it at $1.1555.

Levels Of Support And Resistance For ATOS Stock

The 24-hour chart illustrates a support level at 1.2767, which if violated will result in even more drops to 1.2533. On the upside, there is a resistance level at 1.3267. A further resistance level may holdings at 1.3533. The Relative Strength Index (RSI) on the 14-day chart is 51.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0448, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.72%. Stochastics%K at 34.89% indicates the stock is a holding.

How much short interest is there in Atossa Therapeutics Inc?

A steep rise in short interest was recorded in Atossa Therapeutics Inc stocks on , growing by 2.43 million shares to a total of 12.72 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 10.28 million shares. There was a rise of 19.14%, which implies that there is a positive sentiment for the stock.

Most Popular